HORIZON TECHNOLOGY FINANCE C (HRZN) Fundamental Analysis & Valuation

NASDAQ:HRZN • US44045A1025

Current stock price

4.32 USD
+0.03 (+0.7%)
At close:
4.33 USD
+0.01 (+0.23%)
Pre-Market:

This HRZN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HRZN Profitability Analysis

1.1 Basic Checks

  • HRZN had positive earnings in the past year.
  • HRZN had a positive operating cash flow in the past year.
  • In multiple years HRZN reported negative net income over the last 5 years.
  • In multiple years HRZN reported negative operating cash flow during the last 5 years.
HRZN Yearly Net Income VS EBIT VS OCF VS FCFHRZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.33%, HRZN is doing worse than 76.03% of the companies in the same industry.
  • With a Return On Equity value of -0.84%, HRZN is not doing good in the industry: 71.07% of the companies in the same industry are doing better.
  • Looking at the Return On Invested Capital, with a value of 0.14%, HRZN is doing worse than 70.66% of the companies in the same industry.
Industry RankSector Rank
ROA -0.33%
ROE -0.84%
ROIC 0.14%
ROA(3y)-1.05%
ROA(5y)1%
ROE(3y)-2.61%
ROE(5y)2.03%
ROIC(3y)N/A
ROIC(5y)N/A
HRZN Yearly ROA, ROE, ROICHRZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.37%, HRZN is doing worse than 70.66% of the companies in the same industry.
  • HRZN's Operating Margin has declined in the last couple of years.
  • HRZN has a Gross Margin of 6.12%. This is in the lower half of the industry: HRZN underperforms 67.77% of its industry peers.
  • HRZN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.37%
PM (TTM) N/A
GM 6.12%
OM growth 3Y-58.91%
OM growth 5Y-35.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.81%
GM growth 5Y-24.29%
HRZN Yearly Profit, Operating, Gross MarginsHRZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HRZN Health Analysis

2.1 Basic Checks

  • HRZN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HRZN has been increased compared to 5 years ago.
  • HRZN has a worse debt/assets ratio than last year.
HRZN Yearly Shares OutstandingHRZN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
HRZN Yearly Total Debt VS Total AssetsHRZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • HRZN has an Altman-Z score of -0.05. This is a bad value and indicates that HRZN is not financially healthy and even has some risk of bankruptcy.
  • HRZN has a Altman-Z score of -0.05. This is in the lower half of the industry: HRZN underperforms 75.21% of its industry peers.
  • The Debt to FCF ratio of HRZN is 8.35, which is on the high side as it means it would take HRZN, 8.35 years of fcf income to pay off all of its debts.
  • HRZN has a better Debt to FCF ratio (8.35) than 63.64% of its industry peers.
  • HRZN has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.
  • HRZN has a Debt to Equity ratio of 1.19. This is comparable to the rest of the industry: HRZN outperforms 41.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 8.35
Altman-Z -0.05
ROIC/WACCN/A
WACCN/A
HRZN Yearly LT Debt VS Equity VS FCFHRZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

  • HRZN has a Current Ratio of 1.33. This is a normal value and indicates that HRZN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.33, HRZN perfoms like the industry average, outperforming 58.68% of the companies in the same industry.
  • HRZN has a Quick Ratio of 1.33. This is a normal value and indicates that HRZN is financially healthy and should not expect problems in meeting its short term obligations.
  • HRZN has a Quick ratio (1.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
HRZN Yearly Current Assets VS Current LiabilitesHRZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. HRZN Growth Analysis

3.1 Past

  • The earnings per share for HRZN have decreased strongly by -21.80% in the last year.
  • Measured over the past years, HRZN shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.98% on average per year.
  • HRZN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.33%.
  • HRZN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.34% yearly.
EPS 1Y (TTM)-21.8%
EPS 3Y-10.28%
EPS 5Y-2.98%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)11.33%
Revenue growth 3Y-6.9%
Revenue growth 5Y10.34%
Sales Q2Q%-12.23%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.13% on average over the next years.
  • Based on estimates for the next years, HRZN will show a quite strong growth in Revenue. The Revenue will grow by 19.78% on average per year.
EPS Next Y-1.12%
EPS Next 2Y-2.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.13%
Revenue Next 2Y19.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HRZN Yearly Revenue VS EstimatesHRZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
HRZN Yearly EPS VS EstimatesHRZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. HRZN Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 4.15, the valuation of HRZN can be described as very cheap.
  • 89.26% of the companies in the same industry are more expensive than HRZN, based on the Price/Earnings ratio.
  • HRZN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.79.
  • HRZN is valuated cheaply with a Price/Forward Earnings ratio of 4.20.
  • HRZN's Price/Forward Earnings ratio is rather cheap when compared to the industry. HRZN is cheaper than 93.80% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of HRZN to the average of the S&P500 Index (23.80), we can say HRZN is valued rather cheaply.
Industry RankSector Rank
PE 4.15
Fwd PE 4.2
HRZN Price Earnings VS Forward Price EarningsHRZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, HRZN is valued cheaper than 88.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.53
EV/EBITDA N/A
HRZN Per share dataHRZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • HRZN's earnings are expected to decrease with -2.13% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.13%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HRZN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 11.74%, HRZN is a good candidate for dividend investing.
  • In the last 3 months the price of HRZN has falen by -32.81%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 6.96, HRZN pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, HRZN pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.74%

5.2 History

  • The dividend of HRZN has a limited annual growth rate of 0.33%.
  • HRZN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.33%
Div Incr Years0
Div Non Decr Years0
HRZN Yearly Dividends per shareHRZN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • HRZN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1995.26%
EPS Next 2Y-2.13%
EPS Next 3YN/A
HRZN Yearly Income VS Free CF VS DividendHRZN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

HRZN Fundamentals: All Metrics, Ratios and Statistics

HORIZON TECHNOLOGY FINANCE C

NASDAQ:HRZN (3/18/2026, 8:13:42 PM)

Premarket: 4.33 +0.01 (+0.23%)

4.32

+0.03 (+0.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-03
Earnings (Next)04-27
Inst Owners9.35%
Inst Owner Change20.31%
Ins Owners1.14%
Ins Owner Change0%
Market Cap200.10M
Revenue(TTM)51.77M
Net Income(TTM)-2.66M
Analysts50
Price Target6.94 (60.65%)
Short Float %10.36%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield 11.74%
Yearly Dividend1.24
Dividend Growth(5Y)0.33%
DP-1995.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-18
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.65%
Min EPS beat(2)-39.15%
Max EPS beat(2)9.85%
EPS beat(4)1
Avg EPS beat(4)-12.33%
Min EPS beat(4)-39.15%
Max EPS beat(4)9.85%
EPS beat(8)1
Avg EPS beat(8)-10.24%
EPS beat(12)4
Avg EPS beat(12)-1.08%
EPS beat(16)7
Avg EPS beat(16)-0.3%
Revenue beat(2)1
Avg Revenue beat(2)-6.47%
Min Revenue beat(2)-20.18%
Max Revenue beat(2)7.24%
Revenue beat(4)1
Avg Revenue beat(4)-6.11%
Min Revenue beat(4)-20.18%
Max Revenue beat(4)7.24%
Revenue beat(8)1
Avg Revenue beat(8)-5.54%
Revenue beat(12)4
Avg Revenue beat(12)-2.75%
Revenue beat(16)5
Avg Revenue beat(16)-5.59%
PT rev (1m)0%
PT rev (3m)-0.49%
EPS NQ rev (1m)-23.76%
EPS NQ rev (3m)-24.27%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.69%
Revenue NQ rev (1m)-12.74%
Revenue NQ rev (3m)-12.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE 4.15
Fwd PE 4.2
P/S 3.87
P/FCF 3.53
P/OCF 3.53
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)1.04
EY24.07%
EPS(NY)1.03
Fwd EY23.8%
FCF(TTM)1.22
FCFY28.3%
OCF(TTM)1.22
OCFY28.3%
SpS1.12
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number12.68
Profitability
Industry RankSector Rank
ROA -0.33%
ROE -0.84%
ROCE 0.18%
ROIC 0.14%
ROICexc 0.17%
ROICexgc 0.18%
OM 2.37%
PM (TTM) N/A
GM 6.12%
FCFM 109.39%
ROA(3y)-1.05%
ROA(5y)1%
ROE(3y)-2.61%
ROE(5y)2.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-58.3%
ROICexgc growth 5Y-35.06%
ROICexc growth 3Y-58.47%
ROICexc growth 5Y-35.2%
OM growth 3Y-58.91%
OM growth 5Y-35.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.81%
GM growth 5Y-24.29%
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 8.35
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.04
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z -0.05
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.8%
EPS 3Y-10.28%
EPS 5Y-2.98%
EPS Q2Q%-33.33%
EPS Next Y-1.12%
EPS Next 2Y-2.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.33%
Revenue growth 3Y-6.9%
Revenue growth 5Y10.34%
Sales Q2Q%-12.23%
Revenue Next Year12.13%
Revenue Next 2Y19.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y129.46%
EBIT growth 3Y-61.75%
EBIT growth 5Y-28.59%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1338.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1338.38%
OCF growth 3YN/A
OCF growth 5YN/A

HORIZON TECHNOLOGY FINANCE C / HRZN Fundamental Analysis FAQ

What is the fundamental rating for HRZN stock?

ChartMill assigns a fundamental rating of 3 / 10 to HRZN.


What is the valuation status for HRZN stock?

ChartMill assigns a valuation rating of 6 / 10 to HORIZON TECHNOLOGY FINANCE C (HRZN). This can be considered as Fairly Valued.


Can you provide the profitability details for HORIZON TECHNOLOGY FINANCE C?

HORIZON TECHNOLOGY FINANCE C (HRZN) has a profitability rating of 1 / 10.


What is the valuation of HORIZON TECHNOLOGY FINANCE C based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HORIZON TECHNOLOGY FINANCE C (HRZN) is 4.15 and the Price/Book (PB) ratio is 0.63.


Can you provide the dividend sustainability for HRZN stock?

The dividend rating of HORIZON TECHNOLOGY FINANCE C (HRZN) is 5 / 10 and the dividend payout ratio is -1995.26%.